ZA986903B - Product containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease notably of viral hepatitis - Google Patents

Product containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease notably of viral hepatitis

Info

Publication number
ZA986903B
ZA986903B ZA986903A ZA986903A ZA986903B ZA 986903 B ZA986903 B ZA 986903B ZA 986903 A ZA986903 A ZA 986903A ZA 986903 A ZA986903 A ZA 986903A ZA 986903 B ZA986903 B ZA 986903B
Authority
ZA
South Africa
Prior art keywords
viral
notably
double
treatment
stranded rna
Prior art date
Application number
ZA986903A
Other languages
English (en)
Inventor
De Paillette Evelyne Deschamps
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of ZA986903B publication Critical patent/ZA986903B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA986903A 1997-08-04 1998-07-31 Product containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease notably of viral hepatitis ZA986903B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709975A FR2766715B1 (fr) 1997-08-04 1997-08-04 Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale

Publications (1)

Publication Number Publication Date
ZA986903B true ZA986903B (en) 1999-01-28

Family

ID=9510013

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986903A ZA986903B (en) 1997-08-04 1998-07-31 Product containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease notably of viral hepatitis

Country Status (2)

Country Link
FR (1) FR2766715B1 (fr)
ZA (1) ZA986903B (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin
PH24467A (en) * 1987-03-03 1990-07-18 Hem Res Inc Synergistics interplay of lymphokines and dsrnas
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
AU1820588A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function
DE3853755T2 (de) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnose von Mangelzuständen doppelsträngiger RNS.
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis

Also Published As

Publication number Publication date
FR2766715B1 (fr) 2001-02-16
FR2766715A1 (fr) 1999-02-05

Similar Documents

Publication Publication Date Title
BR9811121A (pt) Produto, composição farmacêutica, e uso de um produto
HK1068548A1 (en) Use of omega interferon in the manufacture of a medicament for treating hepatitis c
EP0772454A4 (fr) Oligonucleotides antisens contre la replication virale de l'hepatite b
NZ289028A (en) Use of antisense nucleic acids in the treatment of skin disease
HU9503751D0 (en) Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
HUP9802493A3 (en) Viral agent associated with mystery swine disease
ZA979096B (en) Viral and cancer treatment
GB2355932B (en) A pharmaceutical formulation suitable for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
HK1041434A1 (zh) 抗病毒藥物和乙型肝炎疫苗的聯合
HK1046428A1 (en) The genome of the hiv-1 inter-subtype (c/b') and use thereof
ZA986903B (en) Product containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease notably of viral hepatitis
IL141211A0 (en) Prevention and treatment of viral disease
USD525706S1 (en) Disposable training pant with elasticized side panels
IL151188A0 (en) Medicament for viral diseases
CS92092A3 (en) Substituted 2',3'-dideoxy-5-trifluoromethyl uridines, process forpreparing thereof and their use in medicaments
NZ325260A (en) Covalent-lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
EP0970189A4 (fr) Modele in vitro destine au vih et a d'autres maladies virales
FR2768345B1 (fr) Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2768344B1 (fr) Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
EP1210088A4 (fr) 2-amino-benzoxazinones destines au traitement de l'herpes simples virus
EP1001966A4 (fr) Gene de senescence et son utilisation dans le traitement du cancer et d'autres maladies
AU2595201A (en) Antiviral therapeutic composition and treatment